Fennec Pharmaceuticals Inc. (NASDAQ:FENC) appears in 88 institutional 13F filings for the quarter ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 31 Mar, 2026 | 2,908,201 | 294,693 | 11.28% | $17,885,436.00 |
| Southpoint Capital Advisors LP | 31 Mar, 2026 | 2,744,741 | 0 | 0.00% | $16,880,157.00 |
| Solas Capital Management, LLC | 31 Mar, 2026 | 2,482,198 | -78,528 | -3.07% | $15,265,518.00 |
| AIGH Capital Management LLC | 31 Mar, 2026 | 1,981,501 | 400,000 | 25.29% | $12,186,231.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,368,176 | 133,899 | 10.85% | $8,414,284.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 897,144 | 897,144 | 0.00% | $5,517,436.00 |
| AWM Investment Company, Inc. | 31 Mar, 2026 | 720,135 | 8,266 | 1.16% | $4,428,830.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 371,738 | 74,638 | 25.12% | $2,286,188.00 |
| State Street Corp | 31 Mar, 2026 | 359,055 | 6,280 | 1.78% | $2,208,188.00 |
| Potomac Capital Management, Inc. | 31 Mar, 2026 | 224,400 | 129,300 | 135.96% | $1,380,060.00 |
| Morgan Stanley | 31 Mar, 2026 | 211,108 | -31,368 | -12.94% | $1,298,314.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 168,473 | 168,473 | 0.00% | $1,036,109.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 153,610 | -46,139 | -23.10% | $944,702.00 |
| Northern Trust Corp | 31 Mar, 2026 | 152,123 | 40,031 | 35.71% | $935,556.00 |
| Lion Point Capital, LP | 31 Mar, 2026 | 112,434 | 0 | 0.00% | $691,469.00 |
| Cornerstone Capital, Inc. | 31 Mar, 2026 | 105,000 | 105,000 | 0.00% | $645,750.00 |
| GENDELL JEFFREY L | 31 Mar, 2026 | 83,024 | -56,535 | -40.51% | $510,597.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 83,005 | 0 | 0.00% | $510,481.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 63,537 | 6,288 | 10.98% | $390,753.00 |
| Nuveen, LLC | 31 Mar, 2026 | 60,948 | 34,942 | 134.36% | $374,831.00 |